At what CAGR is the Transcatheter Aortic Valve Replacement (TAVR) Market anticipated to augment?
Transcatheter Aortic Valve Replacement (TAVR) Market is expected to grow at a CAGR of 7.11% during the forecast period 2023-2030.
. Who are the leading players in the Transcatheter Aortic Valve Replacement (TAVR) Market?
Major key players in the transcatheter aortic valve replacement (TAVR) market are St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, HLT, Inc., JenaValve Technology, Inc., Direct Flow medical, Inc., Meril Life Sciences Pvt. Ltd., Transcatheter Technologies GmbH, SYMETIS SA.
Which region controlled the global market during 2023-2030?
Europe region Controls the Transcatheter Aortic Valve Replacement (TAVR) Market during 2023-2030.
What are the benefits of Transcatheter Aortic Valve Replacement (TAVR)?
TAVR is used to treat aortic stenosis, a condition in which the aortic valve narrows and restricts blood flow from the heart to the rest of the body. Aortic stenosis can cause chest pain, shortness of breath, and fainting.